FIRST MANHATTAN CO. LLC. - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 92 filers reported holding ASCENDIS PHARMA A/S in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2021$9,188,000
-10.3%
69,849
-12.1%
0.03%
-22.7%
Q1 2021$10,246,000
-34.4%
79,508
-15.1%
0.04%
-41.3%
Q4 2020$15,610,000
+8.1%
93,6000.0%0.08%
+1.4%
Q3 2020$14,444,000
+4.3%
93,6000.0%0.07%
-7.5%
Q2 2020$13,843,000
+27.8%
93,600
-2.7%
0.08%
+14.3%
Q1 2020$10,833,000
-17.6%
96,200
+1.8%
0.07%
+6.1%
Q4 2019$13,146,000
+88.3%
94,500
+30.3%
0.07%
+73.7%
Q3 2019$6,983,000
-19.1%
72,500
-3.3%
0.04%
-20.8%
Q2 2019$8,636,000
-2.2%
75,0000.0%0.05%
-5.9%
Q1 2019$8,827,000
-42.1%
75,000
-69.2%
0.05%
-46.3%
Q4 2018$15,243,000
-21.3%
243,306
-11.0%
0.10%
-7.8%
Q3 2018$19,361,000
-18.1%
273,237
-23.1%
0.10%
-24.3%
Q2 2018$23,637,000
+1.7%
355,3480.0%0.14%
+3.0%
Q1 2018$23,239,000
+63.3%
355,3480.0%0.13%
+69.2%
Q4 2017$14,235,000
+10.5%
355,3480.0%0.08%
+5.4%
Q3 2017$12,881,000355,3480.07%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2018
NameSharesValueWeighting ↓
Vivo Capital, LLC 2,003,147$225,574,00020.44%
RA Capital Management 4,914,955$553,473,00017.48%
Sofinnova Investments, Inc. 1,109,874$124,983,00011.56%
Eversept Partners, LP 275,494$31,023,3797.71%
Avoro Capital Advisors LLC 1,787,000$201,234,0006.79%
Orbimed Advisors 3,287,400$370,194,0006.22%
Eventide Asset Management 1,698,648$191,285,0006.19%
Logos Global Management LP 120,000$13,513,0005.14%
Ghost Tree Capital, LLC 150,000$16,892,0004.48%
Spyglass Capital Management LLC 351,388$39,570,0004.47%
View complete list of ASCENDIS PHARMA A/S shareholders